Pan Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
Papers in ⓘ
-
- Circular RNAs in diseases 6
- RNA modifications and cancer 5
- RNA Research and Splicing 3
- Cell death mechanisms and regulation 2
- Cancer-related gene regulation 2
-
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 7
- NF-κB Signaling Pathways 3
- Co-authors
- Qianjin Liao (6 shared papers)Zhaoyang Zeng (6 shared papers)Bo Xiang (6 shared papers)Guiyuan Li (3 shared papers)Zhaojian Gong (4 shared papers)Wenling Zhang (3 shared papers)Xiayu Li (3 shared papers)Ming Zhou (3 shared papers)
- Journals
- Oncotarget (2 papers)Cancer Management and Research (2 papers)Scientific Reports (1 paper)Dalton Transactions (1 paper)Phytotherapy Research (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Pan Chen
37 papers receiving 854 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 475
- Molecular Biology 593
- Oncology 175
- Ophthalmology 40
- Immunology 88
Countries citing papers authored by Pan Chen
This map shows the geographic impact of Pan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan Chen more than expected).
Fields of papers citing papers by Pan Chen
This network shows the impact of papers produced by Pan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan Chen. The network helps show where Pan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Pan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 188 | |
| 2 | 2015 | 98 | |
| 3 | 2020 | 89 | |
| 4 | 2018 | 50 | |
| 5 | 2018 | 47 | |
| 6 | 2019 | 43 | |
| 7 | 2019 | 37 | |
| 8 | 2018 | 28 | |
| 9 | 2018 | 26 | |
| 10 | 2019 | 25 | |
| 11 | 2024 | 22 | |
| 12 | 2021 | 20 | |
| 13 | 2017 | 18 | |
| 14 | 2023 | 18 | |
| 15 | 2023 | 17 | |
| 16 | 2022 | 14 | |
| 17 | 2023 | 13 | |
| 18 | 2024 | 12 | |
| 19 | 2024 | 10 | |
| 20 | 2020 | 8 |
About Pan Chen
Pan Chen is a scholar working on Molecular Biology, Cancer Research, Pharmacology, Oncology and Epidemiology, having authored 38 papers that have together received 857 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (6 papers), RNA modifications and cancer (5 papers), RNA Research and Splicing (3 papers), NF-κB Signaling Pathways (3 papers), Cell death mechanisms and regulation (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Cancer Research (475 citations), Molecular Biology (593 citations), Oncology (175 citations), Ophthalmology (40 citations) and Immunology (88 citations). Pan Chen has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Qianjin Liao, Zhaoyang Zeng, Bo Xiang, Guiyuan Li, Zhaojian Gong, Wenling Zhang, Xiayu Li, Ming Zhou, Lei Shi and Wei Xiong. Their work appears in journals such as Oncotarget, Cancer Management and Research, Scientific Reports, Dalton Transactions and Phytotherapy Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.